⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1804161 | 0.83 | — | — | |
| SCHEMBL592856 | 0.72 | — | — | |
| SCHEMBL11040974 | 0.68 | — | — | |
| SCHEMBL20796853 | 0.68 | — | — | |
| SCHEMBL3450599 | 0.68 | — | — | |
| SCHEMBL18921579 | 0.68 | — | — | |
| SCHEMBL1176138 | 0.68 | — | — | |
| SCHEMBL4753680 | 0.68 | — | — | |
| SCHEMBL5610168 | 0.67 | MAPT (0.35) | — | |
| SCHEMBL289021 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1945605-B1 | PROCESS FOR PREPARING SUBSTITUTED ANISIDINES | BOEHRINGER INGELHEIM INT (DE) | 2013-01-09 | — | — | EP | disclosed |
| EP-1945605-B1 | PROCESS FOR PREPARING SUBSTITUTED ANISIDINES | BOEHRINGER INGELHEIM INT (DE) | 2013-01-09 | — | — | EP | disclosed |
| US-7884246-B2 | starting from substituted cyclic hydroxy-ketones via aromatization through a substituted oxime intermediate; avoids the use of cryogenic conditions, minimizes the number of operations for an overall faster cycle time; in the preperation of drugs for hepatitis C viral infections | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-02-08 | — | — | US | disclosed |
| US-7884246-B2 | starting from substituted cyclic hydroxy-ketones via aromatization through a substituted oxime intermediate; avoids the use of cryogenic conditions, minimizes the number of operations for an overall faster cycle time; in the preperation of drugs for hepatitis C viral infections | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-02-08 | — | — | US | disclosed |
| US-7884246-B2 | starting from substituted cyclic hydroxy-ketones via aromatization through a substituted oxime intermediate; avoids the use of cryogenic conditions, minimizes the number of operations for an overall faster cycle time; in the preperation of drugs for hepatitis C viral infections | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-02-08 | — | — | US | disclosed |
| US-20080293972-A1 | Process for Preparing Substituted Anisidines | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-11-27 | — | — | US | disclosed |
| US-20080293972-A1 | Process for Preparing Substituted Anisidines | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-11-27 | — | — | US | disclosed |
| US-20080293972-A1 | Process for Preparing Substituted Anisidines | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-11-27 | — | — | US | disclosed |
| EP-1945605-A1 | PROCESS FOR PREPARING SUBSTITUTED ANISIDINES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-07-23 | — | — | EP | disclosed |
| WO-2007053755-A1 | PROCESS FOR PREPARING SUBSTITUTED ANISIDINES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-05-10 | — | — | WO | disclosed |
| WO-2007053755-A1 | PROCESS FOR PREPARING SUBSTITUTED ANISIDINES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-05-10 | — | — | WO | disclosed |
| EP-1226146-A2 | QUINOLINE AND NAPHTHYRIDINE CARBOXYLIC ACID ANTIBACTERIALS | ABBOTT LABORATORIES (US) | 2002-07-31 | — | — | EP | disclosed |
| US-20020049223-A1 | Quinoline and naphthyridine carboxylic acid antibacterials | ABBOTT LABORATORIES | 2002-04-25 | — | — | US | disclosed |
| WO-2001032655-A2 | QUINOLINE AND NAPHTHYRIDINE CARBOXYLIC ACID ANTIBACTERIALS | ABBOTT LABORATORIES (US) | 2001-05-10 | — | — | WO | disclosed |